Parkinson’s disease is a common degenerative disorder of the brain. It’s characterized by:
Parkinson’s disease is caused by the loss of dopamine-secreting neurons in a part of the brain called the substantia nigra.
Many drugs are used to manage Parkinson’s disease, and carbidopa-levodopa is the cornerstone of therapy.

Table showing drugs used to treat Parkinson’s disease and their mechanism of action
| Mechanism of action | Generic name and common brands | |
| Increase dopamine levels in the brain | Carbidopa-levodopa (Sinemet, Parcopa, Rytary, Dhivy) | |
| Dopamine agonists that mimic the action of dopamine | Apomorphine (Apokyn, Kynmobi), pramipexole (Mirapex), ropinirole (Requip), rotigotine (Neupro) | |
| MAO-B inhibitors that block the breakdown of dopamine | Rasagiline (Azilect), selegiline (Carbex, Eldepryl) | |
| COMT inhibitors that block the breakdown of dopamine | Entacapone (Comtan), tolcapone (Tasmar), opicapone (Ongentys) | |
| Anticholinergics that block the action of neurotransmitter acetylcholine | Benztropine (Cogentin), trihexyphenidyl (Artane) | |
| Adenosine receptor antagonist | Istradefylline (Nourianz) | |
| Increase dopamine levels in the brain | Fos Levodopa-fos carbidopa (Vyalev, Produodopa) | |
| Unknown mechanisms | Amantadine (Osmolex, Gocovri, Symmetrel) | |
Common adverse effects include:
Anticholinergics are more likely to cause:
Sign up for free to take 5 quiz questions on this topic